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I.INTRODUCTION 
Chronic obstructive pulmonary disease (COPD) is a major cause of 
morbidity, mortality, and health care use. Exercise intolerance is one of 
the most troubling manifestations of COPD. Chronic Obstructive 
Pulmonary Disease (COPD) is a chronic slowly progressive disorder 
characterized by airflow obstruction (reduced FEV1 and FEV1/VC ratio) 
that does not change markedly over several months. In India a median 
prevalence of 5 per cent in men and 2.7 per cent in women was calculated 
which accounted for a total burden of 8.15 million male and4.21 million 
female patients in a population of 944.5 million in 1996. 
The American Thoracic Society and European Respiratory Society 
have defined pulmonary rehabilitation as: “an evidence-based, 
multidisciplinary, and comprehensive intervention for patients with 
chronic respiratory diseases who are symptomatic and often have 
decreased daily life activities. Integrated into the individualized treatment 
of the patient, pulmonary rehabilitation is designed to reduce symptoms, 
optimize functional status, increase participation, and reduce health care 
costs through stabilizing or reversing systemic manifestations of the 
disease” 
Chronic obstructive pulmonary disease (COPD), also known 
as chronic obstructive lung disease (COLD), chronic obstructive airway 
disease (COAD), chronic airflow limitation (CAL) and chronic 
obstructive respiratory disease (CORD), is the co-occurrence of chronic 
bronchitis and emphysema, a pair of commonly co-existing diseases of 
the lungs in which the airways become narrowed. This leads to a 
limitation of the flow of air to and from the lungs, causing shortness of 
breath (dyspnea). In clinical practice, COPD is defined by its 
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characteristically low airflow on lung function tests. In contrast 
to asthma; this limitation is poorly reversible and usually gets 
progressively worse over time. 
COPD is caused by noxious particles or gas, most commonly 
from tobacco smoking, which triggers an abnormal inflammatory 
response in the lung. The diagnosis of COPD requires lung function tests.  
Important  management  strategies  are smoking cessation, vaccinations, 
rehabilitation, and drug therapy. Some patients go on to require long-term 
oxygen therapy or lung transplantation. Worldwide, COPD ranked as the 
sixth leading cause of death in 1990. It is projected to be the fourth 
leading cause of death worldwide by 2030 due to an increase in smoking 
rates and demographic changes in many countries 
Chronic obstructive pulmonary disease, or COPD, is a long-
lasting obstruction of the airways that occurs with chronic 
bronchitis, emphysema, or both. This obstruction of airflow 
is progressive in that it happens over time.  Chronic bronchitis is defined 
as a chronic cough not caused by another condition that produces sputum 
for 3 or more months during each of the 2 consecutive years. In chronic 
bronchitis, the mucous glands in the lungs become larger. The airways 
become inflamed, and the bronchial walls thicken. These changes and the 
loss of supporting alveolar attachments limit airflow by allowing 
the airway walls to deform and narrow the airway lumen .Emphysema is 
an abnormal, permanent enlargement of the air spaces located at the end 
of the breathing passages of the lungs . Emphysema also destroys the 
walls of these air spaces. There are 3 types of emphysema: centriacinar 
emphysema, panacinar emphysema, and distal acinar emphysema or 
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paraseptal emphysema. Cigarette smoking or exposure to tobacco smoke 
is the primary cause of COPD.  
While COPD occurs in 15% of cigarette smokers, tobacco use 
accounts for as much as 90% of the risk for the development of this 
diseases. Secondhand or environmental tobacco smoke also increase the 
risk of respiratory infections and can result in a decrease in lung function. 
People with COPD experience a more rapid decline in what is 
called forced expiratory volume, or FEV1. However, if it does, the effect 
is small when compared to cigarette smoking. The use of solid fuels for 
cooking and heating may cause high levels of indoor air pollution, which 
may then lead to the development of COPD. Some patients who develop 
COPD have airway hyper responsiveness, a condition in which their 
airways overreact to airborne irritants, such as secondhand smoke and air 
pollution. The role of airway hyper responsiveness as a risk factor for 
COPD in people who smoke is unclear. Alpha1-antitrypsin (AAT) is 
a protein in the body that is produced by the liver and helps protect the 
lungs from damage. In AAT deficiency, the liver does not produce 
enough of this protein.   
COPD is typically not diagnosed until the fifth decade of 
life. Common signs and symptoms of COPD are, a productive cough or 
an acute ,breathlessness or being short of breath is the most significant 
symptom, but it does not usually occur until the sixth decade of life, 
wheezing is a musical, whistling, or hissing sound with breathing. Some 
people may wheeze, especially during exertion and when their condition 
worsens.  
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There is a considerable body of evidence that exercise training 
strategies in patients with chronic obstructive pulmonary disease (COPD) 
induce significant improvement in exercise tolerance and quality of life. 
Intensity and duration of exercise are important determinants of the 
physiologic adaptations that occur in response to training. In COPD 
patients there are indications that greater physiological benefits can be 
obtained through high-intensity compared to moderate-intensity 
training. However, high-intensity exercise training may not be applicable 
to those COPD patients who are unable to sustain such intensities for long 
periods of time due to symptom limitation. In fact patients with severe 
COPD are so limited by dyspnea and locomotor muscle weakness that 
their ability to exercise is restricted to very low-intensity levels.  
  Skeletal muscle dysfunction is another major factor that can 
contribute to exercise intolerance. This is evidenced by the findings that 
(1) forced expiratory volume in 1 s (FEV1) alone is a relatively poor 
correlate of exercise tolerance, (2) the perception of leg effort or 
discomfort is the main symptom that limits exercise in 40 to 45 percent of 
patients with COPD, and (3) exercise intolerance often persists after lung 
transplantation, when the patient’s ventilatory limitation has been 
eliminated .Nutritional and psychological factors such as anxiety also 
frequently impact exercise performance. In addition to the above factors, 
the morphological and biochemical changes within the locomotor 
muscles of these patients including abnormal fiber-type distribution, 
reduced fiber cross-sectional areas decreased muscle capillarity and 
oxidative enzyme activities as well as mitochondrial dysfunction are 
associated with an early activation of anaerobic glycolysis, lactic acidosis 
and premature establishment of muscle fatigue during exercise 
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There have been different strategies employed to improve exercise 
capacity in patients with severe COPD, ie, heliox and oxygen 
supplementation, bronchodilator therapy, one-legged training, 
noninvasive mechanical ventilation (NIMV) as well as different training 
modalities of dis-continuous nature inducing lower ventilatory demands 
such as interval or intermittent exercise, upper limb exercise training and 
lower limb exercise training . Furthermore, in the rehabilitation setting 
strategies such heliox supplementation or NIMV would be expensive to 
implement in large cohort of patients whereas upper limb and lower limb 
exercise training could be cost effective and easily applicable 
The amount of air which can be forcibly exhaled from the lungs in 
the first second of a forced exhalation. Measuring FEV1 is done 
through spirometry testing which helps your physiotherapist to determine 
your lung function. Because COPD causes the air in your lungs to be 
exhaled at a slower rate and in a smaller amounts compared to a normal, 
healthy person, measuring how well you can forcibly exhale air can help 
determine the presence of COPD. A decline in FEV causes a person to 
become short of breath and to have difficulty breathing. 
Vital capacity (VC) is the maximum amount of air that can be 
inhaled or exhaled from the lung. It is one of the measurements taken 
during spirometry or pulmonary function testing. VC is measured using 
a spirometer. In COPD the vital capacity is reducing gradually.  
The upper extremities play an important role in many activities of 
daily living such as bathing, dressing, hanging out the wash, and 
gardening. Patients with COPD frequently experience marked dyspnea 
and fatigue when performing these simple tasks. Upper limb activities 
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commonly require unsupported arm exercise, which poses a unique 
challenge for patients with COPD, whose upper limb muscles are 
required to act as accessory muscles of respiration. . During unsupported 
arm exercise, the participation of the accessory muscles in ventilation 
decreases, and there is a shift of respiratory work to the diaphragm .Upper 
limb exercise training included, throwing a ball against the wall with 
arms above horizontal in sitting position, passing a beanbag over the head 
in sitting position, exercises on overhead pulleys in sitting position 
,moving a ring across a wire without touching the wire, while arm was 
above horizontal. 
 Lower-extremity endurance training is considered to be the 
cornerstone of pulmonary rehabilitation. A number of studies have shown 
positive results of this modality of training in pulmonary rehabilitation 
programs. . The lower-extremity exercise protocol was composed of 24 
sessions of cycle training on a cycle ergometer . The patients performed 
three sessions per week, for 8 weeks. Initially, each session consisted of 
30min of continuous cycling at HR peak obtained from the cycle 
ergonometric test 
Conventional physiotherapy techniques like diaphragmatic 
breathing, pursed lip breathing exercises and chest mobilization technique 
are generally given to COPD Subjects. Pursed-lip breathing helps get rid 
of this air. Breathe in slowly through your nose for two seconds. Purse 
your lips like you are going to whistle. Breathe out through pursed lips 
for four seconds or more until your lungs feel empty. Breathe out 
naturally; don't push the air out of your lungs. Diaphragmatic 
breathing: This technique promotes diaphragm use and recruits the lower 
respiratory muscles. Breathe in slowly and deeply through your nose. 
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While breathing in, push your stomach out. Place your hand on your 
stomach so you can feel your stomach going out. Breathe out slowly and 
deeply through your mouth. While breathing out, let your stomach relax. 
Feel your stomach going in with your hand. Count 1, 2 when breathing in. 
Count 1, 2, 3, 4 while slowly breathing out. 
Chest Mobilization Exercise: Make the patient in a comfortable 
setting position with hand rest on the thigh. Ask the patient to breathe in 
slowly and while inspire raise the upper limb in elbow exterior to 180* 
and hold the breath and upper limb to 5 sec. Ask the patient to expire 
slowly and during expiration bring the upper limb to starting position.  
 
1.1  STATEMENT OF THE PROBLEM 
Statement of problem can defined as 
‘Comparative analysis of upper limb and lower limb exercise 
training along with conventional physiotherapy in improving FEV1 and 
vital capacity in COPD subjects’ 
1.2    NEED OF STUDY 
• This study is aimed to find out effects of upper limb exercise 
training in improving FEV1 and vital capacity in COPD subjects. 
• This study is aimed to find out effects of lower limb exercise 
training in improving FEV1 and vital capacity in COPD subjects. 
• This study used to compare the upper limb and lower limb 
exercise training in improving  FEV1 and vital capacity in COPD  
subjects. 
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 1.3  HYPOTHESIS       
1.3.1 Null hypothesis  
There is no significant difference between upper limb and lower 
limb exercise training along with conventional physiotherapy in 
improving FEV1and vital capacity in COPD subjects. 
1.3.2 Alternative hypothesis 
There is significant difference between upper limb and lower limb 
exercise training along with conventional physiotherapy in improving 
FEV1and vital capacity in COPD subjects. 
1.4  OPERATIONAL DEFINITION 
Lower limb exercise training: 
Cycle ergometer training exercise done by the patient as instructed 
by the Physiotherapist. 
Upper limb exercise training: 
Different type of exercises done by the patient by his upper limb 
overhead training in a specific pattern in sitting position. 
Breathing exercise: 
A broad category of physical activity designed to increase strength 
and endurance of the respiratory muscles. 
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II. REVIEW OF LITERATURE  
 
2.1 SECTION A: LITERATURE REGARDING COPD 
 
1. American Thoracic Society,(2004) defined chronic obstructive 
pulmonary disease [COPD] is a preventable and treatable disease state 
characterized by airflow limitation that is not fully reversible. The airflow 
limitation is usually progressive and is associated with an abnormal 
inflammatory response of lungs to noxious particles or gases, primarily 
caused by cigarette smoking. Although COPD affects lungs, it also 
produces significant systemic consequences.  
2.Satsharma et al., (2006) 
Defined COPD as a disease state characterized by the presence of 
airflow obstruction due to chronic bronchitis or emphysema. The airflow 
obstruction generally is progressive, may be accompanied by airway 
hyper reactivity and may be partially reversible. 
3.WHO, (2007) 
 Defined COPD as a disease state characterized by airflow 
limitation that is not fully reversible. The airflow limitation is usually 
both progressive and associated with an abnormal inflammatory response 
of the lung to noxious particles or gases. 
 
4.Hough A, (2005) 
Stated that a common disease entity of chronic bronchitis and 
emphysema is known as chronic obstructive pulmonary disease. COPD is 
a slowly progressive disease and most airways obstruction is fixed, 
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although some reversibility may be demonstrated with medication.  
5.Cigna J .A et al.,(2005)  
defined Chronic obstructive pulmonary disease as a disorder of the 
pulmonary system characterized by limitations in airway flow rates, 
dyspnoea, coughing, abnormal sputum production and an inability to 
tolerate normal functional activities. 
6.British Thoracic Society (1997)  
COPD is defined as chronic slowly progressive disorder 
characterized by airway obstruction(FEV1 <80% predicted & FEV1\FVC 
ratio <70%) which does not change markedly over several months. The 
impairment of lung function is largely fixed but is partially reversible by 
bronchodilator (or other) therapy  
2.2 SECTION B :LITERATURE REGARDING INCIDENCE AND 
PREVALENCE OF COPD 
1.Fabbri L.M et al., (2005) 
 conducted a study and that showed the prevalence of COPD 
determined by criteria of GOLD was 17.2 % among subjects older than 
45 year. Prevalence increased with increasing age, especially in males, in 
those with more than 20 pack, years of smoking, and in low-income 
subjects. 
2.Aggarwal A.N. et al., (2004)  
stated that the prevalence of COPD reported in different population 
studies from India is highly variable. The prevalence rates in male 
subjects of 2.12%studies reported from North are generally higher that 
1.4% to 4.08% reported from South, respective range for female subjects 
vary from 1.3% to 4.9 % from North and from 2.55% to South India. 
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3.Thomson A, (1995)  
Commended that COPD is more common in middle to late adult 
life and in men more than women (ratio 5:1) .It is more common in urban 
areas than in rural areas. 
4.S.K.Jindal et al; (2006)  
Population prevalence of COPD is very high in India with some 
centre to centre differences. COPD was diagnosed in 4.1% of 35295 
subjects with a male to female ratio of 1.56:1 and a smoker to non smoker 
ratio of 2.65:1. Prevalence among bidi and cigarette smokers was 8.2% 
and 5.9% respectively. Odds ratio for COPD was higher for men, elderly 
individuals, lower socio economic status and urban residence.  
5.V.Sobradillo et.al., (2000)  
In their study prevalence of COPD was 9.1%,15% in smokers 
,12.8% in exsmokers and 4.1%in nonsmokers. Prevalence in men was 
14.3% and 3.9% in women.  
2.3 SECTION C: LITERATURE REGARDING ETIOLOGY OF 
COPD 
1.Turato. G et al., (2001)  
Stated that cigarette smoking is currently a casual factor of COPD 
in more than 90 % of patients, indicating that environmental factors are 
involved in the disease. The role of inherited alpha 1 antitrypsin 
deficiency has become well established as a risk factor for COPD. 
2.Satsharma et al., (2006)  
Reported that the primary cause of COPD is exposure to tobacco 
smoke. Clinically significant COPD develops in15 % of cigarette 
smokers. Age of initiation of smoking, total pack-years, and current 
smoking status predict COPD mortality. Airway hyper responsiveness 
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stipulates that patient who has non-specific airway hyper reactivity and 
who smoke are at increased risk of developing COPD with an accelerated 
decline in lung function. 
3.Scanlon P.D, (2004)  
Stated that the primary risk factor for COPD is tobacco use 
(predominantly cigarette smoking). Other factors are airway hyper 
responsiveness, exposure occupational dust and chemicals and genetic 
disorder causing alpha –1-antitrypsin deficiency. 
4.Boggia, (2008) 
 Reported that smoking habits and occupational exposure are 
confirmed as risk factors for COPD. Workers exposed to both risk factors 
have to be considered in COPD high risk class. 
5.Jadwiga a (2002)  
COPD patients have elevated airway cytokine levels suggesting 
that the presence of increase in inflammation may increase their 
susceptibility to exacerbations. Rhinovirus infection is an important 
etiologic factor in COPD exacerbation.  
 
2.4 SECTION D: LITERATURE REGARDING PATHOLOGY OF 
COPD 
1.Celli B. R et al.,(2000) stated that the basic pathophysiologic 
process in COPD consists of increased resistance to airflow, loss of 
elastic recoil, decreased expiratory flow rate and over inflation of lung. 
The hyper inflated lungs flatten the curvature of the diaphragm and 
enlarge the rib cage and these altered configuration of the chest activity 
places the respiratory muscle, including the diaphragm, at a mechanical 
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disadvantage and impairs their force generating capacity, metabolic work 
of breathing increased and increase the sensation of dyspnoea heightens. 
2.Starr J. A,(2001) stated that in COPD chronic inflammation 
from inhaling pollutants causes hypertrophy of glands and goblet cells 
results in excessive mucus production, which either partially or 
completely obstruct the airway. Decrease in ciliary function also impair 
airway clearance and contribute to airway obstruction. When excessive 
secretions are present in an airway, air can be inspired around the 
secretion. During exhalation only small amount of air escapes before the 
airway close down around the secretion, trapping air distal to the mucus 
accounts for hyperinflation. 
3.Turato. G et al.,(2001) describes the major structural and 
cellular changes present in the peripheral airways, central airways and 
lung parenchyma of patients with COPD. The pathological hallmark of 
COPD is emphysema, bronchiolitis, and chronic bronchitis. Airflow 
limitations occur in emphysema by reducing the elastic recoil of the lung 
through parenchyma destruction, bronchiolitis by narrowing and 
obliterating the lumen and chronic bronchitis by mucus hypersecretion. 
The functional consequences of these abnormalities is expiratory airflow 
limitation. As flow is the result of a driving pressure and of an opposing 
resistance, it is refer to the changes in flow seen in smokers as airflow 
limitation, rather than airflow obstruction. Since both loss of elastic recoil 
and increase in airway resistance play an important role in decrease in 
flow. 
4.Russell M,(2000) study suggests that smoking inadvertently 
damages the lining of the airway. As with any other part of the body in 
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response to injury, inflammation occurs. Inflammation stimulates the 
damaged lining to secrete mucus in an abnormal amount and also causes 
the airway to constrict. 
5. Shapiro S.D and Ingenito E.P, (2005) stated that in COPD the 
pathological changes mainly affect the large airway, small airways and 
alveolar space. Large airway changes consist of mucus gland enlargement 
and goblet cell hyperplasia. The major site of increased resistance in most 
individuals with COPD in airway 2mm or less. Characteristic cellular 
changes include goblet cell metaplasia and replacement of surfactant 
secreting Clara cells with mucus secreting and infiltrating mononuclear 
inflammatory cells. Smooth muscle hypertrophy may also present. These 
abnormalities may cause luminal narrowing by excess mucus, oedema, 
and cellular infiltration. Fibrosis in the wall may cause airway narrowing 
directly and predispose to non-specific hyper reactivity. Changes in 
alveolar space are characterized by chronic inflammation and destruction 
with coalescence in to larger alveolar spaces. 
6 .Henke O.M et al.,(2005) commended that the anatomic 
disruption, ciliary impairment, plasma exudation and fibrin can change 
the viscoelasticity of the mucus and impair the surfactant properties of the 
airway lining material cause small airway obstruction and gas trapping. 
These changes in mucus clearance lead to ventilation-perfusion 
mismatch, impaired gas exchange, pulmonary hyperinflation, and 
inspiratory loading of the respiratory muscles leading to fatigue and 
ineffective cough. 
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2.5 SECTION E : LITERATURE REGARDING DIAGNOSIS AND 
INVESTIGATIONS OF COPD 
 
 1. Watchie J, (1996) stated that FEV1 is valuable in assessing 
the severity of airway obstruction. FEV1 /FVC is the forced expiratory 
volume in one second expressed as a percentage of forced vital capacity. 
Normal FEV1 is ≥ 75-80% of predicted and FEV1/FVC is 90%. In 
obstruction both FEV1and FEV1 /FVC is decreased. 
2. Bowes M,(2001) suggested that the history is very important 
when considering a diagnosis of COPD and should include the patient’s 
exposure to risk factors, smoking history and any respiratory or other 
medical conditions such as asthma or childhood respiratory tract 
infections. The most important test for verifying COPD is spirometry. 
Number of signs are evident upon physical examination including chest 
wall abnormalities such as barrel chest, hyperinflation of the lungs, low 
diaphragm position, diminished heart or breath sounds and rapid shallow 
respirations. The patient may also exhibit pursed lip breathing, the use of 
accessory respiratory muscles and retraction of intercostals spaces.   
3.Fabbri L.M et al., (2005) stated that FEV1 remains the reference 
marker for diagnosis, assessment of severity and prognosis. Other lung 
function parameters may also be useful in assessing COPD. Low body 
weight in patients with COPD is associated with impaired pulmonary 
status, reduced diaphragmatic mass, low exercise capacity and higher 
mortality rate when compared with adequately nourished individuals with 
this disease. 
 
 
 
 
 
16 
 
4.Allen M.B et al., (2005) stated that the patient with COPD will 
have impairment of expiratory flow , best measured by spirometry. Blood 
gases should be performed to identify the severity of hypoxemia and 
decide if oxygen therapy is required. Chest X -ray is important, not for 
confirming the diagnosis of COPD but to exclude the other reasons for 
the presentation. 
5. Starr J.A, (2001) reported that arterial blood gas analysis might 
reflect hypoxemia in the early stages of COPD. Hypercapnea appears as 
the disease progresses. With the disease progression, chest radiographs 
show several characteristic findings. These include depressed and 
flattened hemi diaphragms; alterations in pulmonary vascular markings; 
hyperinflation of the thorax evidenced by an increased antero-posterior 
diameter of the chest; and an increased retro sternal air space, 
hyperlucency, elongation of the heart and right ventricular hypertrophy. 
 
2.6 SECTION F: LITERATURE REGARDING OUTCOME 
MEASURES OF COPD 
Pulmonary Function Test 
1.Gildea T R, (2003) stated that pulmonary function testing is a 
valuable tool for the evaluation of the respiratory system. 
 
2. Collins J.V, (1993) suggested that simple measurements of 
FEV1, PEFR and FVC are useful for diagnosing airway obstruction. 
FEV1, PEFR and FVC will be reduced but the reduction in FEV1 and 
PEFR is usually greater than FVC fall and FEV1/FVC ratio will be less.. 
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 3. Pierce R., (2005) stated that the degree of reversibility of an 
obstructive defect could be detected by measuring spirometry before and 
after administration of bronchodialator. An improvement in FEV1 of 
200ml or more infers significant reversibility, if the baseline FEV1 is <1.5 
L, as does an improvement of >15 % if the FEV1 is > 1.5 L 
4.Sat Sharma et al., (2006) stated that pulmonary function test are 
essential for the diagnosis and assessment of severity of disease, and they 
are helpful in following its progress. Lung volume measurements in 
COPD may document an increase in total lung capacity, functional 
residual capacity and residual volume and decrease in vital capacity . 
5. Celli B.R et al; (2000) stated that the diagnosis of COPD should 
be considered in any patient who has the followings symptoms: cough; 
sputum production; or dyspnoea; or history of exposure to risk factor for 
the disease. Post bronchodialator spirometry is required to confirm the 
diagnosis of chronic obstructive lung disease. COPD presently is graded 
using a single measurement such as forced expiratory volume in one 
second. 
6.Allen M.B et al; (2005) stated that the airflow limitation in 
COPD is best measured as forced expiratory volume in one second 
(FEV1) and this relates mortality. Lung function testing along with high-
resolution thoracic computerized tomography (CT) scanning can result in 
a reasonably confident result. 
2.7 SECTION G : LITERATURE REGARDING PHYSIOTHERAPY 
MANAGEMENT OF COPD 
1.Faling J.L, (2002) stated that controlled breathing techniques 
and chest physical therapy are the major component of rehabilitation of 
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patients with COPD. The goal of chest physical therapy is to facilitate the 
removal of excess secretions, thus reducing the resistance airflow and the 
work of breathing, improving pulmonary gas exchange. 
2.Pryor J.A et al., (2004) commended that breathing control and 
relaxation positions improved the exercise tolerance in breathlessness 
patient. When the patient is sitting or standing, leaning forward, the 
abdominal contents raise the anterior aspect of the diaphragm and 
probably facilitating its contraction during inspiration. 
3.  Cigna J A et al., (2005) mentioned that the main components 
of chest physical therapy used to treat patients with COPD are : 
Positioning, Manual Techniques, Coughing Techniques, Breathing 
Techniques. Huffing avoids the dynamic airway collapse, bron 
choconstriction and fatigue associated with uncontrolled forceful 
coughing. 
4.Massery M and Frownfelter D,(2003) commended that patients 
with primary lung disease use their accessory muscles greatly increase the 
work of breathing secondary to the shortness of breath or coughing. 
Combination of relaxed diaphragmatic breathing and pursed lip breathing 
reduces the work of breathing in patients with COPD 
5.  Hough A, (2005) found that physiotherapy is often required to 
help clear secretions and reduce work of breathing including non-invasive 
ventilation to prevent intubation. Physiotherapy must include educating 
the patient and family about restoration and maintenance of exercise 
tolerance and basic self-management. 
6. Innocenti D M, Anderson J.M, (1993) found that in chronic 
stage of COPD, chest shaking on expiration would assist in the removal 
of secretions. Effective huffing and coughing should be interspersed with 
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periods of relaxed diaphragmatic breathing. All patients should be taught 
diaphragmatic breathing and shown how to control breathing during 
attacks of dyspnoea. All breathless patients should be taught to control 
their breathing when walking on the floor or upstairs and hills. 
7.Kakizaki et al., (1999) mentioned that thoracic mobility 
exercises reduced breathlessness and increased vital capacity in COPD 
patients. 
 
2.8 SECTION H: LITERATURE REGARDING RESPIRATORY 
MUSCLES COPD 
1.Crane L D , (1998) mentioned that the sternocledomastoid 
muscle moves the rib cage superiorly which expands the upper rib cage in 
the pump handle motion. Two important functions of the scalenes are that 
they counteract the downward pull of the parasternals on the sternum and 
expands the upper rib cage in its anterior posterior dimensions. The 
accessory muscles of inspiration assist in increase in thoracic diameters 
by moving rib cage up and out ward when the shoulder girdle is fixed. 
2.Ferguson (1993) Lung Hyperinflation reduces the zone of 
apposition of the diaphragm. The net effect is decreased ability of the 
diaphragm to elevate the ribcage.  
3.Reid W D and Dechman G, (1995) stated that during quite 
inspiration in asymptomatic, the respiratory muscles contract in a 
coordinated fashion such that the diaphragm descends in a piston like 
fashion and the ribs move upward and outward. Activities such as 
exercise or even breathing at rest in individuals with respiratory diseases 
demand increased levels of ventilation which may require recruitment of 
both accessory inspiratory and expiratory muscles. 
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4.Orozco-Levi M, (2003) mentioned that respiratory muscles are 
essential for alveolar ventilation. These muscles work against increased 
mechanical loads due to airflow limitation and geometrical changes of the 
thorax derived from pulmonary hyperinflation in COPD patients. 
5.Lyn Hobson, (2003) diaphragm is the principal muscle of 
respiration. It is estimated that two thirds of the vital capacity in all 
positions is contributed by diaphragm. In forced inspiration when the 
arms are fixed Pectoralis major draws the ribs toward the arms there by 
increasing thoracic diameter and pectoralis minor contract to elevate the 
ribs to which they are attached.  
6.Hough A, (2005) found that COPD patients may lean forward on 
their elbows to force their diaphragm into a more efficient dome shape 
and stabilize the shoulder girdle for optimum accessory muscle action. 
Some patients can only inhale by lifting up their entire rib cage with their 
accessory  muscles. 
7.Joanne Watchie, (1995 )abdominals force diaphragm back to 
resting position and depress and compress lower thorax leading to 
increase in intra thoracic pressure which, which is essential for coughing.   
8.Sue Jenkins , (2004) Normally expiration is passive, but with a 
decrease in expiratory airflow the patient may recruit the abdominal 
muscles and other expiratory and inspiratory muscles in an attempt to 
augment expiration 
2.9 SECTION I : LITERATURE REGARDING UPPER LIMB AND 
LOWER LIMB EXERCISE TRAINING OF COPD 
1.Carolyn L. Rochester, MD(2001) Exercise training in chronic 
obstructive pulmonary disease the rationale for and outcomes of lower- 
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and upper-limb training, as well as ventilatory muscle training, are 
reviewed, and the potential for anabolic hormone supplementation to 
optimize  the benefits of exercise training is discussed. 
2.F. Pittaa, A.F. Brunettoa,(1998) Effects of Isolated Cycle 
Ergometer Training on Patients with Moderate-to-Severe Chronic 
Obstructive Pulmonary Disease.Despite the within-group changes, no 
between-group significant differences were observed. In COPD patients, 
the results of isolated low-to-moderate intensity cycle ergometer training 
are not comparable to effects of multimodality and high-intensity training 
programs. 
3.Janet l. Larson, margaret k.(1996) Cycle Ergometer and 
Inspiratory Muscle Training in Chronic Obstructive Pulmonary Disease 
Home-based CET produced a physiological training effect and reduced 
exercise-related symptoms while IMT increased respiratory muscle 
strength and endurance. The combination of CET and IMT did not 
produce additional benefits in exercise performance and exercise- related 
symptoms. This is the first study to demonstrate a physiological training 
effect with home-based exercise training. 
4.V. S. Probst, T. Troosters (2001) Cardiopulmonary stress 
during exercise training in patients with COPD. The cardiopulmonary 
stress resistance training is lower than during whole-body exercise and 
results in fewer symptoms. In addition, exercise testing based on 
guidelines using a fixed percentage of baseline peak performance and 
symptom scores achieves and sustains training intensities recommended 
according to the American College of Sports Medicine. 
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5. Karla Gale, MS (1990) Upper Arm Exercises Improve Vigor in 
COPD Patients, Unexpected was the improvement of general exercise 
capacity, the authors add, surpassing the minimal clinically important 
difference for patients with COPD. 
 6.StefaniaCosti, Mauro Di Bari(2003) Short-term Efficacy of 
Upper-Extremity Exercise Training in Patients With Chronic Airway 
Obstruction: A Systematic Review  This systematic review shows that 
there is limited evidence examining UEET and that the evidence available 
is of poor quality. Therefore, a recommendation for the inclusion or 
exclusion of UEET in pulmonary rehabilitation programs for individuals 
with CAO is not possible. Further research is needed to definitively 
ascertain the effects of this training modality on patient-centered 
outcomes 
7.VillaPineta Hospital ,University of Modena and Reggio 
Emilia(2007) 
Efficacy of Arm Training in COPD Patients (UEET-COPD),Upper 
limb training for patients COPD improves upper limb exercise capacity, 
but has no additional effect on symptoms or quality of life, as compared 
with leg training alone. 
8.Subin,Vaishali Rao(2005) Effect of upper limb, lower limb and 
combined training on health-related quality of life in COPD .The 
combined upper limb and lower limb training group showed a significant 
improvement in the exercise performance and health related quality of 
life. 
9.GanesanKathiresan(1995) Review Article Effect of upper 
extremity exercise in people with COPD, This review suggests that in the 
 
 
 
 
 
23 
 
short term, arm endurance training improves arm exercise capacity and 
arm strength training improves arm strength. Further research is required, 
in people with COPD, to investigate the long-term effects of arm training. 
10.Anne E. Holland(2000) Does Unsupported Upper Limb 
Exercise Training Improve Symptoms and Quality of Life for Patients 
With Chronic Obstructive Pulmonary Disease? Unsupported upper limb 
training for patients COPD improves upper limb exercise capacity, but 
has no additional effect on symptoms or quality of life, as compared with 
leg training alone. This type of upper limb training may not adequately 
address the complex interaction between respiratory mechanics and upper 
limb function. 
11CarolynKisner Lynn AlenColby, Therapeutic Exercise 
Foundation and Technique 3rd edition p664-665 
Breathing exercise are corporate in into the overall pulmonary 
rehabilitation of program of patients with acute and chronic pulmonary 
disorder. Breathing exercise are designed to retain the muscle of 
respiration improve or redistribute ventilation, lessen the work of 
breathing, improve gaseous exchange ,oxygenation. 
12.AshaHasimy MohdHasim, DrZainal Abidi, ,Muscle activity 
during diaphragmatic breathing compared to abdominal crunches –
A pilot study 
Diaphragmatic breathing exercise are designed to improve the 
efficiency of ventilation ,decreased work of breathing. It is always used to 
mobilize the secretion during postural drainage. 
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13.CarolynKisner Lynn Alen Colby Therapeutic Exercise p671 
 Diaphragmatic breathing is 3 dimensional involving all sides 
of lower ribs .It is done with the middle of torse involving a gentle 
expansion of lower rib as the diaphragm draws downward. This 
diaphragmatic breathing is marked by the expansion of abdomen rather 
than chest when breathing .it is the most efficient breathing compared to 
other techniques 
14.CarolynKisner Lynn Alen Colby Therapeutic Exercise p671 
 It is thought to be keep airways open by creating a back 
pressure in the airways. It is thought to help a patient with COPD studies 
suggest that purse lip breathing decreases respiratory rate and increases 
tidal volume and tolerance  
15. Jennifer A ProyrAmnani Prasad  Physiotherapy for respiratory 
condition 3rd edition 
Purse lip breathing is often used in patients severe airway disease. 
By opposing the lips during expiration the airway pressure inside the 
chest is maintained preventing the floppy airways from collapsing  
16.E.H.Breslinn the pattern of respiratory muscle recruitment in 
purse lip breathing A chest journal 
Purse lip breathing is performed as expiratory blowing against 
pursed lip is a pulmonary rehabilitation strategy incentively or voluntary 
employed in patients with COPD to control dypsnoea. It provides 
apperception of control over breathing 
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3. METHODOLOGY 
3.1 Study design  
Pre test and post test Comparative study 
• Group A: lower limb exercise training group along with 
conventional physiotherapy 
• Group B:upper limb exercise training group along with   
conventional physiotherapy 
 3.2 Source of data 
      MAGJ HOSPITAL, Mookkannoor, Ernakulam. Kerala 
3.3 Sample and Sampling method:      
       20 subjects were selected and randomly assigned in to one of 
the two training groups 
3.4 Inclusion criteria  
• COPD above 45 years -60 years. 
• Both male and female. 
• Patients with chronic bronchitis. 
• Patient had air flow obstruction. (FEV, FEC is <80%)    
 3.5 Exclusion criteria: 
•   Patients with unstable cardiac disease 
•   Acute rib fracture  
•   Subject not able to do PFT 
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•   Patients with TB, 
•   Pneumonia 
•   Carcinoma of lung 
•   Psychiatric illness 
 3.6 Variables 
 Dependent Variables: 
1. FeV1 
2. Vital capacity 
 Independent Variables: 
1. Upper limb exercise training 
2. Lower limb exercise training  
3. Conventional physical therapy. 
3.7 Tools and Materials: 
 1. Pulmonary function test – using  spirometer 
3.8 Procedure  
The patient in Group A  were instructed for upper limb exercise 
training along with conventional Physiotherapy. 
The patients in Group B lower limb exercise training along with  
conventional  Physiotherapy. 
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Treatment Procedure: 
The two groups are instructed to do exercise for once daily for 
eight weeks. 
Upper limb exercise training 
Patients in this group had 10 minute of general warm up 
progressive upper limb training, and 10 minute of cool down 
 Upper limb exercise training in clued  
1 throwing a ball against the wall with arms above horizontal in 
sitting position 
 
Passing a beanbag over the head in sitting position. Exercises on over 
head pulleys in sitting position  
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Moving a ring across a wire without touching the wire, while arm was 
above horizontal 
 Duration: Each exercise was performed for 40 seconds followed 
by 20 seconds rest. Exercises would be repeated four times in four 
minutes. Minimum exercise training time is 30 minute .the patient un able 
to do 30 minute time, are progressively attain this duration at his 10th 
session 
     1.  Warm up and cool down exercise for this section  
      2. Shoulder flexion extension 
      3. Shoulder abduction and adduction  
      4. Shoulder rotation 
      5. Elbow flexion and extension  
      6. Wrist flexion and extension  
      7 . Exercise is performed for 5 times for both upper limbs 
           Lower limb exercise training: 
 
The training program took place in the outpatient respiratory unit 
of the hospital . The lower-extremity exercise protocol was composed of 
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24 sessions of cycle training on a cycle ergometer. The patients 
performed three sessions per week, for 8 weeks. Initially, each session 
consisted of 30 min of continuous cycling at 80% HRpeak obtained from 
the cycle ergonometer test. If the target of 30 min of continuous exercise 
was not possible to reach in the first sessions, the patients were allowed to 
cycle less time, keeping the intensity at 80% of HRpeak. In this case, the 
time of continuous cycling was gradually increased until the patient 
reached the 30-min target, which was achieved by all the patients until 
the 10th session. The increase in load during the 2 months was adapted 
according to the dyspnea ratings . After an initial period of 2 weeks , or 
until the patient was able to cycle continuously during 30 min the load 
was periodically adjusted to correspond to a dyspnea sensation scored by 
the patient as around 5–6 in a Borg scale . Any patient who showed 
SpO2 <90% during exercise received oxygen by nasal canulae. In this 
case, the oxygen flow (1–3 liters/min) was adjusted as the minimum 
necessary to keep SpO2 >90%. 
Conventional physiotherapy:  
Diaphragmatic breathing exercise: 
Prepare the patient in relaxed and comfortable position in reclined 
settling. Place therapist hand on rectus abdomen just below the anterior 
costal margin 
Ask the patient to breathe slowly and deeply through nose. Have 
the patient keep shoulders relaxed and upper chest quiet allowing 
abdomen to rise 
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Then tell the patient to slowly at all air out using controlled 
expiration through mouth. 
Practice this three or four limits and then rest do not allow the 
patient to hyperventilate, fore lift and prolonged expiration should be 
avoid. 
Pursed Lip Breathing: 
Prepare the patient in relaxed and comfortable position such is half 
lying. 
Explain the patient that expiration must be relaxed (passive) and 
that contraction of abdominals must be avoided 
Place therapist hand over the patient’s abdominal muscle to detect 
any contraction of abdominals. Instruct the patient to breathe in slowly 
and deeply then have the patient loosely purse the lips and exhale slowly 
twice as long inhalation patient is discouraged to perform forceful or 
prolonged expiation during the performance of the exercise. 
Chest Mobilization Exercise: 
Make the patient in a comfortable setting position with hand rest on 
the thigh. Ask the patient to breathe in slowly and while inspire raise the 
upper limb in elbow exterior to 180* and hold the breathe and upper limb 
to 5 sec. 
The ask the patient to expire slowly and during expiration bring the 
upper limb to starting position.  
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Measurement procedure 
Pulmonary function testing is a method of determining how well 
lungs and airways are working. These tests may be done on a routine 
basis. It gives the Physiotherapist a series of numbers, which allows them 
to compare each patient’s lung function with a predicted value based on 
age, height, and sex, as well as their lung function in the past. 
The most common pulmonary function test is called a spirometry. 
During this test patient is asked to take in as deep a breath as possible, 
and blow out all of the air as fast and as hard as you can. Patients will 
make several attempts at this procedure to assure that the best 
performance has been measured.  
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IV. DATA ANALYSIS & RESULT 
4.1 Data Analysis 
Paired’ – test 
The intra group analysis of results were done with Paired ‘t’ test 
with 5% level of significance. 
Statistical analysis is done by using dependent ‘t’ test 
                         s
ndt =  
                 s = 1
)( 22
−
−∑ ∑
n
n
d
d
 
d = difference between the pre-test Vs. post test 
d = mean difference 
n= number of observations 
s = standard deviation 
 
To compare control Group and Experimental Group 
Statistical analysis is done by using Unpaired ‘t’ test 
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Where 
S =  Combined standard deviation 
d1 and d2        =  Difference between initial and final readings in  
 control group  and experimental group  
 respectively. 
 n1       =   No. of patients in control group  
n2        =   No. of patients in experimental group 
21 XX and     =     Mean of control Group and experimental  
   Group respectively. 
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4.2 RESULTS 
The number of subjects for the study were 20 (n=20). The subjects 
were divided in to two groups. For one group A (10 subjects) upper limb 
exercise training was given and for other group B (10 subjects) lower 
limb exercise training was given. 
The subjects were given training for 2 months continuously. 
Before starting the training pretest value is measured. The measurement 
was repeated after the training (post test value). Reading pre and post test 
value of group A and B are given in table. Thus in both groups there was 
significant improvement scores of FEV1 and vital capacity. 
When analyzing the fev1values of group A, by paired ‘t’ test the 
calculated t value for is 94.88 and ‘t’ table value is 4.78  at 0.001 level. 
Since the calculated ‘t’ value is more than ‘t’ table value, it is concluded 
that there is significant difference in the pre and post test values of FEV1 
following upper limb training among COPD subjects.  
When analyzing the FEV1 values of group B, by paired ‘t’ test the 
calculated t value is 8.978  and ‘t’ table value is 4.78  at 0.001 level. 
Since the calculated ‘t’ value is more than ‘t’ table value, it is concluded 
that there is significant difference in the pre and post test values of FEV1 
following lower limb training among COPD subjects. 
 When comparing both group values of FEV1 by unpaired ‘t’ test 
the calculated t value is 24.34 and ‘t’ table value is 3.92  at 0.001 level. 
Here since the calculated ‘t’ value is more than ‘t’ table value, it is 
concluded that there is significant difference among upper limb training 
and lower limb training in improving FEV1 among COPD subjects.oke 
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patient. Hence the alternate hypothesis is accepted and null hypothesis is 
rejected. 
When analyzing the vital capacity values of group A, by paired ‘t’ 
test the calculated t value is 23.46  and ‘t’ table value is 4.78  at 0.001 
level. Since the calculated ‘t’ value is more than ‘t’ table value, it is 
concluded that there is significant difference in the pre and post test 
values of FEV1 following upper limb training among COPD subjects.  
When analyzing the vital capacity values of group B, by paired ‘t’ 
test the calculated t value is 9.291 and ‘t’ table value is  4.78  at 0.001 
level. Since the calculated ‘t’ value is more than ‘t’ table value, it is 
concluded that there is significant difference in the pre and post test 
values of FEV1 following lower limb training among COPD subjects.  
When comparing both group values of vital capacity by unpaired 
‘t’ test the calculated t value is 25.32 and ‘t’ table value is 3.92 at 0.001 
level. Here since the calculated ‘t’ value is more than ‘t’ table value, it is 
concluded that there is significant difference among upper limb training 
and lower limb training in improving FEV1 among COPD subjects.oke 
patient. Hence the alternate hypothesis is accepted and null hypothesis is 
rejected. 
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V. DISCUSSION 
       American Thoracic Society defined chronic obstructive pulmonary 
disease [COPD] is a preventable and treatable disease state characterized 
by airflow limitation that is not fully reversible. The airflow limitation is 
usually progressive and is associated with an abnormal inflammatory 
response of lungs to noxious particles or gases, primarily caused by 
cigarette smoking. Although COPD affects lungs, it also produces 
significant systemic consequences. 
      In current study compare two groups , group A and group B. Group A 
getting upper limb exercise training along with conventional 
physiotherapy and group b getting lower limb exercise training along 
with conventional physiotherapy. Pre and post test done during the 
treatment period.  
      Efremidis G, Tsiamita M Accuracy of pulmonary function tests in   
predicted exercise capacity in COPD patients. They stated that conclude 
that exercise capacity was predicted from measurements of resting 
pulmonary function parameters with excellent accuracy in the COPD 
patient. . So present study included “Pulmonary function test “ for cardio 
pulmonary function.  
Ries AL, Ellis B, Hawkins RW Upper extremity exercise training 
in chronic obstructive pulmonary disease. In this study shows 
improvement in the lung function according to his result.  
      L. LARSON JANET, Cycle Ergometer and Inspiratory Muscle 
Training in Chronic Obstructive Pulmonary Disease in this study the 
researcher state that lower limb training is beneficial in copd and it 
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increases the lung function . 
Ries AL, Ellis B , Hawkins RW in their study shows that FEV1 
and vital capacity are improved and also patients show improving there 
upper arm muscle power . The upper extremities play an important role in 
many activities of daily living such as bathing, dressing, hanging out the 
wash, and gardening. Patients with COPD frequently experience marked 
dyspnea and fatigue when performing these simple tasks. Upper limb 
activities commonly require unsupported arm exercise, which poses a 
unique challenge for patients with COPD, whose upper limb muscles are 
required to act as accessory muscles of respiration. This study shows 
improvement in cardiopulmonary. 
        L. LARSON JANET, Cycle ergometer training also improves the vital 
capacity and FEV1 in COPD patients. Walking and stair climbing are 
difficult to COPD patients and in daily living activity it is more 
important. During this study patient shows improvement in walking and 
other daily living activity. According to this study patient shows 
improvement in cardiopulmonary functions.       
      In this present study found that both upper limb and lower limb 
exercise training is beneficial to increase fev1 and vital capacity in COPD 
subjects .hence this study shows upper limb exercise training group 
shows more improvement in COPD subjects. 
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VI. CONCLUSION 
Chronic obstructive pulmonary disease defined as a usually 
progressive with air flow limitation that is not fully reversible and that is 
associated with abnormal inflammatory response of the lungs to noxious 
particles or gases. Physical therapy combining breathing exercise, chest 
Physiotherapy, are used. This study projects that both upper limb and 
lower limb training are effective in the treatment options in COPD. 
When comparing the mean value of all the group, Group A which 
received upper limb training showed more difference than other two 
group which received lower limb training. Hence we can conclude that 
upper limb training are more effective than lower limb training in 
improving FeV1among COPD patients. 
LIMITATIONS 
• Food habits, extremely  cold food like, ice cream etc.  
• Personal habits like smoking, alcoholism, tobacco 
• Exposure to climate. 
• The subjects do not have any follow up programme.  
• Size of the sample was very small which might affect the outcome 
RECOMMENDATION 
• To establish the efficiency of the treatment a large sample size 
study is required. 
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• For more valid result, a long term study must be carried out.  
• Follow up programs can be included to assess the long term 
effects of treatment. 
• Further study can be conducted to check the effects of these 
techniques on other respiratory conditions. 
• Specific condition wise study can be conducted. 
• Other pulmonary variable can be included. 
•  The study can be done with a large sample size. 
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VIII ANNEXURE 
ANNEXURE-1 
RESPIRATORY ASSESMENT FORM 
Subjective assessment 
Name 
Age  
Sex 
Occupation 
Chief complaints 
Present medical history 
Past medical history 
Personal history 
History of allergens 
History of immunization 
Associated problems 
Family history 
Socio economic history  
Psychological history 
Subjective evaluation of cardinal symptoms 
1.Pain 
  Pleuritic 
  Muscle 
  Skeletal  
 Neuralgic 
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  Angina 
2.Cough 
 A . Effectiveness 
 B. Variation 
 C. Productive/non productive 
3 Sputum 
A. Color  
B. Constituency 
C. Smell 
D. Quantity 
4.Dysnoea 
  1-sterenous activity 
   2-on ordinary activity 
  3- on < ordinary activity 
  4-at rest 
5.Wheeze 
   Diurinal variations 
   Postural variations 
   Aggravating factors 
Objective assessment  
Vitals 
  Pulse rate 
  Respiratory rate 
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 Blood pressure 
  Temperature 
On observation 
A. level of consciousness 
B. built of patient 
C. posture 
D. head and face evaluation 
color 
Distress 
Puffiness 
E. Neck 
Usage of accessory muscles 
Distention of viens 
F. Chest 
Expansion  
Unmoving chest 
Deformity 
Moving chest 
  Pattern of breathing    rate     depth       rhythm 
  I:e ratio 
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Symmetry of movement 
External of movement 
G. Extremity evaluation 
Clubbing 
Edema 
Cyanosis 
Tremor 
Skin changes 
H. External appliances 
On palpation  
A. Tracheal shift 
B. Tenderness 
C. Chest expansion 
      Auxiliary level 
      Nipple level 
      Xiphi sternal level 
D. Accessory muscle palpation 
E. Tactile fremitus 
F. Movement of diaphragm 
 
On Percussion 
Resonant 
Hyper resonant 
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Hypo resonant 
Dull 
On auscultation 
Normal sounds 
Tracheal 
Bronchial 
Broncho vesicular 
Vesicular 
Voice sounds 
Broncho phony 
Ego phony 
Whispering pectoriloquy 
Added sounds 
Wheeze 
Crepitus 
Pleural rub 
Pericardial rub 
Heart sounds 
On examination 
Chest expansion 
Spirometry 
Musculoskeletal assessment  
Neuromuscular assessment 
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ANEXXURE -II 
FeV1 SCORE 
Table :7 
Group A Group B 
Pre test     Post test   Pretest Post test 
2.26      3.34 2.27 2.5 
2.27      3.33    2.3      2.52 
2.28      3.39    2.4      2.70 
2.28      3.36    2.20 2.35 
2.27  3.38 2.40 2.57 
2.26 3.34 2.47 2.60 
2.26      3.35     2.56     2.67 
2.27 3.39 2.20 2.50 
2.28 3.38 2.30 2.45 
2.26      3.39 2.40 2.56 
 
Table :7 shows pre and post test of FEV1  
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 VITAL CAPACITY SCORE 
Table:8 
Group A Group B 
Pre test     Post test   Pretest Post test 
3.17 4.02 3.40 3.6 
3.19 4.01 3.2 3.5 
3.20 4.03 3.34 3.46 
3.16 4.03 3.56 3.70 
3.17 4.02 3.52 3.76 
3.18 4.01 3.27 3.57 
3.20 4.01 3.30 3.50 
3.19 4.03 3.52 3.76 
3.18 4.02 3.40 3.52 
3.17 4.01 3.50 3.65 
 
Table : 8 shows pre and post test value of Group A and Group B 
vital capacity data’s 
        
 
 
  
 
 
 
 
 
57 
 
ANEXXURE -III 
 
PATIENT CONSENT FORM  
I ………………………………………………. Voluntarily consent to 
participate in the research named on study “COMPARETIVE 
ANALYSIS OF UPPER AND LOWER LIMB EXERCISE TRAINING 
ALONG WITH CONVENTIONAL PHYSIOTHERAPY IN 
INMPROVING FeV1 AND VITAL CAPACITY IN COPD    
SUBJECTS “  
 
 
 
Signature of patient                Signature of researcher  
 
 
